CLINICAL_TRIALS
trial_result
· 2016-10-10
Clinical Trial Update: Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults [Phase 3]
Summary
Phase 3 trial update on nasal glucagon for treating hypoglycemia in adults with type 1 diabetes; results completed with posted data.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2016-10-10